News
Texas Instruments stock remains stable after Truist Securities reiterated its Hold rating and $171 target, despite trading ...
Adell Harriman & Carpenter Inc. raised its Citigroup holdings by 18.6% in the first quarter, reaching 82,067 shares worth ...
The lack of details about which countries are involved and which companies will be impacted as a result of the new trade deal ...
Home Depot's SRS subsidiary acquired GMS for $4.3 billion to strengthen its penetration in the professional market with ...
Shares of Sweetgreen ( SG) were down 8.9% at 11:40 a.m. to trade close to their 2025 lows. Short interest on Sweetgreen ( SG) ...
FedEx’s second quarter results were met with a negative reaction from the market, as flat sales and persistent headwinds ...
Boot Barn’s first quarter was marked by robust sales growth and a strong market reaction, with investors responding favorably ...
StockStory.org on MSN19h
5 Revealing Analyst Questions From GoodRx’s Q1 Earnings CallGoodRx’s first quarter results were met with a positive market response, reflecting management’s progress in refocusing the ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results